Search | Page 11 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

    ... GVHD is one of the most common complications of a stem cell transplant . Status:  ...

    Clinical Trial last updated 04/29/2016 - 12:40pm.

  2. Total Marrow Irradiation for Refractory Acute Leukemia

    ... before a donor umbilical cord blood or hematopoietic stem cell transplant helps stop the growth of cancer cells. It may also ... Other Names: umbilical cord blood allogeneic hematopoietic stem cell transplantation Biological: Granulocyte ...

    Clinical Trial last updated 05/02/2016 - 9:22am.

  3. Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoing Donor Peripheral Blood Stem Cell Transplant

    ... hematologic malignancies undergoing donor peripheral blood stem cell (PBSC) transplant. Giving chemotherapy and total-body ... Intervention:  Procedure: Allogeneic Hematopoietic Stem Cell Transplantation Undergo allogeneic ...

    Clinical Trial last updated 04/28/2016 - 12:07pm.

  4. Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients

    ... Purpose:  Allogeneic transplant can sometimes be an effective treatment for leukemia. In ... infusion of their donor's bone marrow or blood stem cells . The high-dose chemotherapy drugs and radiation are given to ...

    Clinical Trial last updated 05/09/2016 - 3:01pm.

  5. Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

    ... the patient's immune system from rejecting the donor's stem cells . When the healthy stem cells from an unrelated donor , ... Intervention:  Procedure: Allogeneic Hematopoietic Stem Cell Transplantation Undergo umbilical cord ...

    Clinical Trial last updated 04/28/2016 - 1:52pm.

  6. Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

    ... the patient's immune system from rejecting the donor's stem cells . When the healthy stem cells from a donor are infused into the ... Intervention:  Procedure: Allogeneic Bone Marrow Transplantation Undergo donor bone marrow ...

    Clinical Trial last updated 04/29/2016 - 12:48pm.

  7. Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation

    ... intervention to improve the recovery following hematopoietic stem cell transplantation (HSCT). Cancer patients who were treated with HSCT ... types) receiving standard conditioning regimens Allogeneic transplant recipients undergoing fully ablative transplants ...

    Clinical Trial last updated 04/29/2016 - 10:30am.

  8. Busulfan and Cyclophosphamide Followed By ALLO BMT

    ... who are at least 6 months after initial hematopoietic stem cell transplant (HSCT) <45 years of age and have received ... unless no engraftment. Other Name: MMF Biological: Allogeneic hematopoietic stem cell transplant Day 0 (or Day+1/+2 to ...

    Clinical Trial last updated 04/29/2016 - 1:23pm.

  9. Incidence and Burden of the Myelodysplastic Syndromes

    ... may be considered for a clinical trial or allogeneic stem cell transplant if available.  This is a large unmet need in MDS.  ...

    Research Review last updated 05/02/2016 - 9:11am.

  10. Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Sy

    ... the patient's immune system from rejecting the donor's stem cells . Also, radiolabeled monoclonal antibodies, such as iodine I 131 ... Intervention:  Procedure: Allogeneic Bone Marrow Transplantation Given via central line Other ...

    Clinical Trial last updated 04/28/2016 - 1:01pm.